These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1380608)

  • 61. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
    Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Renal responses to atrial natriuretic peptide are preserved in bilateral ureteral obstruction and augmented by neutral endopeptidase inhibition.
    Ryndin I; Gulmi FA; Chou SY; Mooppan UM; Kim H
    J Urol; 2005 Feb; 173(2):651-6. PubMed ID: 15643282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat.
    Golin R; Protasoni G; Wjinmaalen P; Sala C; Monopoli A; Casati C; Zanchetti A; Stella A
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):665-71. PubMed ID: 8945680
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
    Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure.
    Kentsch M; Otter W; Drummer C; Nötges A; Gerzer R; Müller-Esch G
    Eur J Clin Pharmacol; 1996; 51(3-4):269-72. PubMed ID: 9010697
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
    Stasch JP; Knorr A; Wegner M; Hirth-Dietrich C
    Hypertens Res; 1995 Jun; 18(2):137-43. PubMed ID: 7584920
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure.
    Yasuhara M; Yamaguchi M; Shimizu H; Hashimoto Y; Hama N; Itoh H; Nakao K; Hori R
    Pharm Res; 1994 Dec; 11(12):1726-30. PubMed ID: 7899235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats.
    Trippodo NC; Gabel RA; Harvey CM; Asaad MM; Rogers WL
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):308-16. PubMed ID: 1720829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
    Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modification of the renal response to endopeptidase inhibition and atrial natriuretic peptide infusion in normal dogs.
    Levy M; Cernacek P
    Can J Physiol Pharmacol; 1992 Dec; 70(12):1563-70. PubMed ID: 1301233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.
    Dessì-Fulgheri P; Sarzani R; Serenelli M; Tamburrini P; Spagnolo D; Giantomassi L; Espinosa E; Rappelli A
    Hypertension; 1999 Feb; 33(2):658-62. PubMed ID: 10024323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.